PharmaCyte Biotech, Inc.
PMCB · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $9 | $20 | $57 | $36 |
| - Cash | $15 | $50 | $68 | $85 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6 | -$30 | -$11 | -$49 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $31 | $7 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Net Income | $31 | $0 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | 3.19 | -1.8 | -0.83 | -0.79 |
| % Growth | 277.2% | -116.9% | -5.1% | – |
| Operating Cash Flow | -$3 | -$2 | -$4 | -$4 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$2 | -$4 | -$4 |